Al-Maidan Clinic for Oral Health Services Company K.S.C.P. (KWSE:MIDAN)

KWSE:MIDAN Financials Overview

Financials in millions KWD. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	63.39	63.17	72	75.75	72.6	70.82
Revenue Growth	-6.68%	-12.26%	-4.96%	4.35%	2.52%	16.21%
Gross Profit Gross Profit Growth	15.57	15.04	18.84	22.12	24.91	23.81
Operating Income Operating Income Growth	7.76	6.75	6.12	9.8	12.89	13.2
Net Income Net Income Growth	10.65	9.52	9.27	11.82	12.18	10.28
Earnings Per Share EPS Growth	0.05	0.05	0.05	0.06	0.05	0.05
EPS Growth	27.01%	2.70%	-20.07%	5.22%	19.09%	31.70%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Hospital Hospital Growth	58.2	58.01	65.69	68.66	65.61	62.98
Clinics Clinics Growth	5.19	5.16	6.31	7.1	6.99	7.83
Total Total Growth	63.39	63.17	72	75.75	72.6	70.82

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	51.16	47.37	53.39	48.35	41.32	34.08
Total Debt Total Debt Growth	1.46	1.61	1.72	2.49	2.92	1.68
Net Cash (Debt) Net Cash Growth	49.7	45.76	51.67	45.86	38.4	32.4
Net Cash Growth	3.09%	-11.44%	12.66%	19.43%	18.50%	57.54%
Net Cash Per Share Net Cash Per Share Growth	0.25	0.23	0.26	0.22	0.17	0.14

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	12.98	11.78	8.52	14.43	15.17	21.38
Capital Expenditures CapEx Growth	-6.13	-6.08	-1.52	-1.85	-1.55	-1.44
Free Cash Flow Free Cash Flow Growth	6.84	5.7	7.01	12.57	13.62	19.94
Free Cash Flow Growth	5.46%	-18.66%	-44.28%	-7.64%	-31.72%	189.08%

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	24.57%	23.81%	26.17%	29.20%	34.32%	33.62%
Operating Margin	12.25%	10.69%	8.50%	12.94%	17.76%	18.64%
Pretax Margin	17.04%	15.28%	13.07%	15.80%	16.99%	14.69%
Profit Margin	16.79%	15.07%	12.87%	15.60%	16.78%	14.52%
FCF Margin	10.80%	9.02%	9.73%	16.60%	18.75%	28.16%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Aug 28, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Dividend Per Share Dividend Per Share Growth	0.020	0.020	0.015	0.010	0.006
Dividend Per Share Growth	500.00%	33.33%	50.00%	78.57%	-
Dividend Yield	2059.73%	2.64%	2.11%	2.48%	0.88%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 28, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	19.02	17.66	17.42	7.85	12.12	14.96
P/FCF Ratio	29.59	29.49	23.04	7.38	10.84	7.71
PS Ratio	3.19	2.66	2.24	1.22	2.03	2.17

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 26, 2026

Data Sources Report a data error